Moderna to Test Coronavirus Vaccine Booster Shot in New Clinical Trial - Motley Fool
Morgan Healthcare Conference, Moderna said it plans to do so in a clinical trial involving participants of earlier studies of the vaccine, mRNA-1273.
"From what we've seen so far, I think our expectation is that the vaccination should last you at least a year," Moderna Chief Medical Officer Tal Zaks said during the conference.In the planned study, Moderna will try to determine the level of immune response still being generated by the booster shot, CEO Stephane Bancel said at the event.The timing is right for a follow-up study, as the participants in the first clinical trials of the vaccine are nearing their one-year anniversary of receiving the booster.